LFBC(SZ:002513) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2026-02-26 22:37Core Viewpoint - The major shareholder, Hainan Wenqin Private Fund Management Partnership, has reduced its stake in Jiangsu Lanfeng Biological Chemical Co., Ltd. to below 5%, resulting in a change in its shareholder status [2][3]. Group 1: Shareholder Reduction Details - Hainan Wenqin held 33,610,000 shares, representing 8.99% of the total share capital as of September 27, 2023, and has reduced its holdings to 18,779,677 shares, which is 4.99999% of the current total share capital [4][15]. - The reduction occurred through block trades and centralized bidding, with a total of 9,795,589 shares sold from September 4 to September 9, 2025, and an additional 3,564,760 shares sold on February 13, 2026 [4][15]. - The final reduction of 1,448,974 shares occurred on February 24 and 25, 2026, leading to Hainan Wenqin no longer being classified as a major shareholder [4][15]. Group 2: Impact on Company Control - The reduction in Hainan Wenqin's shareholding will not lead to a change in the company's controlling shareholder or actual controller [3][6]. - The company's governance structure and ongoing operations will remain unaffected by this change in shareholding [6][16]. Group 3: Share Capital Changes - The company's total share capital increased from 373,936,278 shares to 375,593,978 shares due to the implementation of an equity incentive plan, which passively diluted Hainan Wenqin's shareholding percentage [5][15]. - The changes in shareholding were disclosed in accordance with relevant laws and regulations, ensuring compliance with the requirements for shareholder reductions [6][16].